Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2012
05/03/2012US20120107408 Pharmaceutical microparticles
05/03/2012US20120107402 Process for analyzing and establishing dosage size in an ingestible film
05/03/2012US20120107400 Sustained release composition of theraputic agent
05/03/2012US20120107394 Immuno-compatible hydrogel system
05/03/2012US20120107378 High strength carbo substances
05/03/2012US20120107377 Particulate composition and pharmaceutical composition containing the same
05/03/2012US20120107371 Stimuli-responsive systems for controlled drug delivery
05/03/2012US20120107368 Compressible tablet material having an oil-containing active substance, tablet as well as method and device for the production thereof
05/03/2012US20120107365 Films and particles
05/03/2012US20120107264 Nucleic acid delivery compounds
05/03/2012US20120107254 Long Wear Topical Composition
05/03/2012US20120107241 Particles for Inhalation Having Sustained Release Properties
05/03/2012US20120107235 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof
05/03/2012US20120105558 aqueous ink jet ink comprising a crosslinking pigment dispersion based on diblock polymeric dispersants
05/03/2012CA2852210A1 Composition and method for treating wounds
05/03/2012CA2824471A1 Cross-linked polymers and implants derived from electrophilically activated polyoxazoline
05/03/2012CA2818931A1 Process for analyzing and establishing dosage size in an ingestible film
05/03/2012CA2817068A1 Therapeutic solution concentrate
05/03/2012CA2816418A1 Novel formulations of water-insoluble chemical compounds and methods of using a formulation of compound fl118 for cancer therapy
05/03/2012CA2816171A1 Liposomal drug composition containing a polymeric guanidine derivative
05/03/2012CA2816119A1 Ternary mixture formulations
05/03/2012CA2816052A1 Liquid formulations of long acting interferon alpha conjugate
05/03/2012CA2815960A1 Tau imaging probe
05/03/2012CA2815888A1 Clostridium difficile-specific antibodies and uses thereof
05/03/2012CA2815277A1 Novel egfr-binding molecules and immunoconjugates thereof
05/03/2012CA2815267A1 Spider silk fusion protein structures for binding to an organic target
05/03/2012CA2813833A1 Liposome-based construct comprising a peptide modified through hydrophobic moieties
05/03/2012CA2811805A1 Solid dispersions containing an apoptosis-inducing agent
05/02/2012EP2447282A2 Anti-CD22 Antibodies, their Immunoconjugates and uses thereof
05/02/2012EP2446904A2 Anti-CD22 antibodies, their immunoconjugates and uses thereof
05/02/2012EP2446890A1 High viscosity macromolecular compositions for treating ocular conditions
05/02/2012EP2446881A1 Orally Dissolving Films
05/02/2012EP2446878A1 Ketorolac tromethamine compositions for treating or preventing ocular pain
05/02/2012EP2446031A1 Stabilizing alkylglycoside compositions and methods thereof
05/02/2012EP2445932A1 Soricidin derived peptides and methods for the detection of trpv-6 cancers and drug delivery
05/02/2012EP2445588A2 Topical formulation containing a tetracycline and a method of treating skin infections using the same
05/02/2012EP2445537A1 Conjugates of cytotoxic drugs
05/02/2012EP2445536A1 Methods and compositions using peptides and proteins with c-terminal elements
05/02/2012EP2445535A2 Terpene glycosides and their combinations as solubilizing agents
05/02/2012EP2445508A1 Nitric oxide therapies
05/02/2012EP2445482A1 Method for preparing an enriched igg composition from plasma
05/02/2012EP2234645B1 Peg-interferon-beta formulations
05/02/2012EP2178900B1 Purification of pegylated polypeptides
05/02/2012EP1945217B1 Combinations comprising a vegf receptor inhibitor and a penetration enhancer
05/02/2012EP1819230B1 Red cell-derived microparticles as hemostatic agents for the control of hemorrhage and for treatment of bleeding disorders
05/02/2012EP1733720B1 Composition comprising reduced-form coenzyme q10 and carotenoid compound
05/02/2012EP1666020B1 Compositions for the preparation of carbon dioxide gel for external use and carbon dioxide gels for external use
05/02/2012EP1638609B1 Method for the preparation of molecular complexes
05/02/2012EP1528933B1 Pharmaceutical anti-tnf-alpha antibody formulation
05/02/2012EP1507796B1 Cross-linked glycopeptide-cephalosporin antibiotics
05/02/2012EP1492511B3 Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
05/02/2012EP1429723B1 Treating effects of excessive reactive oxygen species
05/02/2012EP1418893B1 Compositions and techniques for localized therapy of restenosis
05/02/2012CN1404398B Improved DNA vaccines for production-type animals
05/02/2012CN102438657A Methods of identifying potential components for targeted drug delivery compositions
05/02/2012CN102438656A Pretargeting kit, method and agents used therein
05/02/2012CN102438655A Plant fiber product and method for its manufacture
05/02/2012CN102438646A Treatment of metastatic tumors
05/02/2012CN102438623A Solid preparation containing npy y5 receptor antagonist
05/02/2012CN102438617A Matrix-type sustained release preparation containing basic additive
05/02/2012CN102438606A Coenzyme q10 nanoparticles, preparation method thereof and composition containing said nanoparticles
05/02/2012CN102438602A An improved dry powder drug delivery system
05/02/2012CN102438601A Electrostatically charged multi-acting nasal application, product and method
05/02/2012CN102438596A Dosage form for insertion into the mouth
05/02/2012CN102438589A Oily suspension containing probiotic bacteria for paradiatric uses
05/02/2012CN102436885A Method for dispersing iron-based magnetic nanocrystals
05/02/2012CN102432974A Polymer vesica with antibacterial nano silver deposited on surface and preparation method thereof
05/02/2012CN102432886A Preparation method of star-type polylactic-acid grafting sodium alginate particles and applications thereof
05/02/2012CN102432783A PH response/hydrophobic group random copolymerization polymer, and preparation method and application thereof
05/02/2012CN102432774A Biodegradable temperature response hydrogel and preparation method thereof
05/02/2012CN102432755A Multi-targeted photodynamic therapy polymer carrier and preparation method thereof
05/02/2012CN102432747A Amine lactone type amphoteric high polymer emulsion as well as preparation method and application thereof
05/02/2012CN102432737A Controlled-release enteric acrylic resin latex and preparation method thereof
05/02/2012CN102432736A Method for preparing monodisperse molecularly imprinted polymer nano-microspheres
05/02/2012CN102432695A Synthetic method of N-2-hydroxypropyl trimethyl ammonium chloride chitosan and preparation method of Newcastle disease attenuated live vaccine-loaded nanoparticles of N-2-hydroxypropyl trimethyl ammonium chloride chitosan
05/02/2012CN102432649A High yield method of producing pure rebaudioside A
05/02/2012CN102432024A Hollow mesoporous silica microsphere, preparation method and application thereof
05/02/2012CN102430147A Biodegradable strontium-doped calcium sulfate material having biological activity, and its preparation method and use
05/02/2012CN102430129A Bone morphogenetic protein-2/basic fibroblast growth factor (BMP-2/bFGF) double-gene chitosan nano-microcapsules and application thereof
05/02/2012CN102430127A Method for preparing berberine inclusion compound in carbon dioxide medium
05/02/2012CN102430126A Heat-resistant stabilizer for tissue fluid lyophilization, as well as preparation method and application thereof
05/02/2012CN102430125A Heat-resistant stabilizer for chicken embryos fluid lyophilization, as well as preparation method and application thereof
05/02/2012CN102430124A Pill coating with ultralow friction coefficient and preparation method thereof
05/02/2012CN102430123A PH-sensitive organic and inorganic composite medicament delivery system and preparation method thereof
05/02/2012CN102430122A Fluoxertine hydrochloride orally disintegrating tablet and preparation method thereof
05/02/2012CN102430121A Method for preparing aminated carbon nano tube
05/02/2012CN102430116A Dry heat treatment method for human coagulation factor VIII preparation and dry heat treatment stabilizer
05/02/2012CN102430102A Preparation method for huangqi-guizhi-wuwu granule
05/02/2012CN102430093A Micro-sphere injection capable of resuscitating consciousness and preparation method thereof
05/02/2012CN102430028A Chinese medicinal patch for treating polycystic ovary syndrome and preparation method thereof
05/02/2012CN102430020A Process method for leading easily-layered paste material to be uniform in production of compound south-star pain relieving paste
05/02/2012CN102430014A Preparation method of oral preparation of jichuan-decoction granules
05/02/2012CN102429986A Traditional Chinese ointment for treating burn and scald and preparation method thereof
05/02/2012CN102429943A Sugar-free erigeron breviscapus mixture and preparation method thereof
05/02/2012CN102429919A Water-soluble vitamin combination medicine
05/02/2012CN102429903A Ozagrel sodium medicinal composition for injection
05/02/2012CN102429897A Pharmaceutical composition for improving oral bioavailability of morin
05/02/2012CN102429893A Anti-inflammation and anti-allergy canker sore treating medicament and preparation method thereof
05/02/2012CN102429892A Levalbuterol sulfate pulsatile capsule and preparation method thereof
05/02/2012CN102429890A Medicinal composition containing cells and application thereof
1 ... 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 ... 1712